RxDoctor Payments DataLook up a doctor →

Shelby Hites

Psychiatric/Mental Health · New Castle, PANPI 1316373491

Payments from drug & device makers

$9,491in general payments, 2019–2025

Across 585 payments — averaging $16.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Alkermes, Inc.$940
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$932
  • Teva Pharmaceuticals USA, Inc.$811
  • Otsuka America Pharmaceutical, Inc.$754
  • Takeda Pharmaceuticals U.S.A., Inc.$694
  • plus $4K from 27 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie85$1,309
Alkermes, Inc.49$940
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)58$932
Teva Pharmaceuticals USA, Inc.52$811
Otsuka America Pharmaceutical, Inc.44$754
Takeda Pharmaceuticals U.S.A., Inc.64$694
Lundbeck LLC35$549
Axsome Therapeutics, Inc.29$440
Collegium Pharmaceutical, Inc.29$423
Johnson & Johnson23$404
Vanda Pharmaceuticals Inc.16$342
Neurocrine Biosciences, Inc.13$235
Supernus Pharmaceuticals, Inc.6$229
Corium, LLC13$211
Otsuka Pharmaceutical Development & Commercialization, Inc.10$193
Sunovion Pharmaceuticals Inc.10$165
Idorsia Pharmaceuticals US Inc7$161
Ironshore Pharmaceuticals Inc.7$132
Avanir Pharmaceuticals, Inc.8$126
Merck4$62
Acadia Pharmaceuticals Inc4$57
Eisai Inc.3$41
Tris Pharma Inc2$40
Neos Therapeutics, LP2$37
Almatica Pharma LLC2$35
Avion Pharmaceuticals2$33
Azurity Pharmaceuticals, Inc.2$30
Adlon Therapeutics L.p.1$23
Indivior Inc.1$22
Sage Therapeutics, LLC1$19
Noven Therapeutics, LLC1$14
Sun Pharmaceutical Industries Inc.1$14
Noven Pharmaceuticals, Inc.1$13

How this compares

$9,491 in reported general payments places this provider in the 95th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

See all psychiatric/mental health providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$3,479
Medicare patients
18
Services billed
35

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other psychiatric/mental health in New Castle

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →